The US Left Atrial Appendage Closure Device Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)
The report titled “The US Left Atrial Appendage Closure Device Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the US left atrial appendage closure device market by value, by product, by procedure, by end-user, etc. The report also provides a detailed analysis of the COVID-19 impact on the left atrial appendage closure device market.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall left atrial appendage closure device market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US left atrial appendage closure device market is fragmented with many major market players operating worldwide. The key players of the left atrial appendage closure device market are Johnson & Johnson, Abbott, Boston Scientific and Atricure are also profiled with their financial information and respective business strategies.
Country Coverage
Left atrial appendage closure is a nominal invading surgery that is done to decrease the chance of stroke that happens due to atrial fibrillation (also called as Afib or AF). Left atrial appendage closure is also called LAAC or LAA closure. Atrial fibrillation is a usual type of arrhythmia, a situation in which human heart beats out of rhythm. LAA closure equipment provides blood clot control as a substitute to blood thinners.
The US Left atrial appendage closure device market can be segmented on the basis of product, endoscopes, Epicardial left atrial appendage closure device and endocardial left atrial appendage closure device; on the basis of procedure, such as percutaneous and surgical and on the basis of end-users, such as hospitals, ambulatory surgery centres and others.
The US left atrial appendage closure device market has increased significantly during the years 2016-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The left atrial appendage closure device market is expected to increase due to aging population, growing gross national income, increasing prevalence of atrial fibrillation, increasing healthcare spending worldwide, growing urbanization and rising adoption of minimally invasive procedure. Yet, the market faces some challenges such as high cost of left atrial appendage closure procedure & equipment, unfavorable reimbursement policies in developing countries and high degree of competition.
The COVID-19 pandemic had a positive impact on the market because when restrictions were lifted people were getting their procedures done immediately as heart patients have lower survival chances if they catch coronavirus.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall left atrial appendage closure device market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The US left atrial appendage closure device market is fragmented with many major market players operating worldwide. The key players of the left atrial appendage closure device market are Johnson & Johnson, Abbott, Boston Scientific and Atricure are also profiled with their financial information and respective business strategies.
Country Coverage
- The US
- Johnson & Johnson
- Abbott
- Boston Scientific
- Atricure
Left atrial appendage closure is a nominal invading surgery that is done to decrease the chance of stroke that happens due to atrial fibrillation (also called as Afib or AF). Left atrial appendage closure is also called LAAC or LAA closure. Atrial fibrillation is a usual type of arrhythmia, a situation in which human heart beats out of rhythm. LAA closure equipment provides blood clot control as a substitute to blood thinners.
The US Left atrial appendage closure device market can be segmented on the basis of product, endoscopes, Epicardial left atrial appendage closure device and endocardial left atrial appendage closure device; on the basis of procedure, such as percutaneous and surgical and on the basis of end-users, such as hospitals, ambulatory surgery centres and others.
The US left atrial appendage closure device market has increased significantly during the years 2016-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The left atrial appendage closure device market is expected to increase due to aging population, growing gross national income, increasing prevalence of atrial fibrillation, increasing healthcare spending worldwide, growing urbanization and rising adoption of minimally invasive procedure. Yet, the market faces some challenges such as high cost of left atrial appendage closure procedure & equipment, unfavorable reimbursement policies in developing countries and high degree of competition.
The COVID-19 pandemic had a positive impact on the market because when restrictions were lifted people were getting their procedures done immediately as heart patients have lower survival chances if they catch coronavirus.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Heart: Overview
2.2 Functions of Heart
2.3 Structural Heart Problem: Overview
2.4 Types of Treatments Structural Heart Problems
2.5 Left Atrial Appendage Closure Device: Overview
2.6 Left Atrial Appendage Closure Device Segmentation: Overview
3. THE US MARKET ANALYSIS
3.1 The US Left Atrial Appendage Closure Device Market: An Analysis
3.1.1 The US Left Atrial Appendage Closure Device Market by Value
3.1.2 The US Left Atrial Appendage Closure Device Market by Product (Epicardial Left Atrial Appendage Closure Device and Endocardial Left Atrial Appendage Closure Device)
3.1.3 The US Left Atrial Appendage Closure Device Market by Procedure (Percutaneous and Surgical)
3.1.3 The US Left Atrial Appendage Closure Device Market by End-Users (Hospitals, Ambulatory Surgery Centres and Others)
3.2 The US Left Atrial Appendage Closure Device Market: Product Analysis
3.2.1 The US Epicardial Left Atrial Appendage Closure Device Market by Value
3.2.2 The US Endocardial Left Atrial Appendage Closure Device Market by Value
3.3 The US Left Atrial Appendage Closure Device Market: Procedure Analysis
3.3.1 The US Percutaneous Left Atrial Appendage Closure Device Market by Value
3.3.2 The US Surgical Left Atrial Appendage Closure Device Market by Value
3.4 The US Left Atrial Appendage Closure Device Market: End-User Analysis
3.4.1 The US Hospital Left Atrial Appendage Closure Device Market by Value
3.4.2 The US Ambulatory Surgery Centres Left Atrial Appendage Closure Device Market by Value
3.4.3 The US Other Left Atrial Appendage Closure Device Market by Value
4. IMPACT OF COVID-19
4.1 COVID-19 Impact on Global Left Atrial Appendage Closure Device Market
4.2 Impact of COVID-19 on Health Services Spending
4.3 Leading Causes of Death in the US
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Aging Population
5.1.2 Growing Disposable Income
5.1.3 Increasing Prevalence of Atrial Fibrillation
5.1.4 Increasing Healthcare Spending Worldwide
5.1.5 Growing Urbanization
5.1.6 Rising Adoption of Minimally Invasive Procedure
5.2 Challenges
5.2.1 High Cost of Left Atrial Appendage Closure Procedure & Equipment
5.2.2 Unfavorable Reimbursement Policies in Developing Countries
5.2.3 High Degree of Competition
5.3 Market Trends
5.3.2 Partnerships among Major Players
5.3.2 Growing Healthcare Market in Emerging Economies
6. COMPETITIVE LANDSCAPE
6.1 The US Left Atrial Appendage Closure Device Market Players: Financial Comparison
6.2 The US Left Atrial Appendage Closure Device Market Players: R&D Comparison
7. COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Abbott
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Boston Scientific
7.3.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.4 AtriCure
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Functions of Heart
Figure 2: Types of Treatments Structural Heart Problems
Figure 3: Segmentation of Left Atrial Appendage Closure Device by Product and End-Users
Figure 4: The US Left Atrial Appendage Closure Device Market by Value; 2016-2020 (US$ Billion)
Figure 5: The US Left Atrial Appendage Closure Device Market by Value; 2021-2025 (US$ Billion)
Figure 6: The US Left Atrial Appendage Closure Device Market by Product; 2020 (Percentage, %)
Figure 7: The US Left Atrial Appendage Closure Device Market by Procedure; 2020 (Percentage, %)
Figure 8: The US Left Atrial Appendage Closure Device Market by End-Users; 2020 (Percentage, %)
Figure 9: The US Epicardial Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 10: The US Endocardial Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 11: The US Percutaneous Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 12: The US Surgical Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 13: The US Hospital Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 14: The US Ambulatory Surgery Centres Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 15: The US Others Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 16: The US Year-on Year Growth Rate of Health Services Spending by Quarter; (Percentage, %)
Figure 17: Average Daily Deaths in the US; February 2021 (per Day)
Figure 18: The US Population; 2000-2040 (Percentage, %)
Figure 19: The US Total Personal Disposable Income (DPI); 2018-2023 (US$ Billion)
Figure 20: The US Atrial Fibrillation in Adults; 2015-2035 (Million)
Figure 21: Global Healthcare Spending; 2017-2022 (US$ Billion)
Figure 22: The US Urban Population; 2016-2020 (Million)
Figure 23: The US Minimally Invasive Surgery Market Size; (US$ Million)
Figure 24: Johnson & Johnson Net Sales; 2016-2020 (US$ Billon
Figure 25: Johnson & Johnson Net Sales by Segments; 2020 (Percentage, %)
Figure 26: Johnson & Johnson Net Sales by Regions; 2020 (Percentage, %)
Figure 27: Abbott Net Sales; 2016-2020 (US$ Billon)
Figure 28: Abbott Net Sales by Segments; 2020 (Percentage, %)
Figure 29: Abbott Net Sales by Regions; 2020 (Percentage, %)
Figure 30: Boston Scientific Net Sales; 2016-2020 (US$ Billon)
Figure 31: Boston Scientific Net Sales by Segments; 2020 (Percentage, %)
Figure 32: Boston Scientific Net Sales by Regions; 2020 (Percentage, %)
Figure 33: Atricure Revenue; 2016-2020 (US$ Million)
Figure 34: Atricure Revenue by Segments; 2020 (Percentage, %)
Figure 35: Atricure Revenue by Regions; 2020 (Percentage, %)
Table 1: The US Left Atrial Appendage Closure Device Market Players: Financial Comparison; 2020
Table 2: The US Left Atrial Appendage Closure Device Market Players: R&D Comparison; 2016-2020
2. INTRODUCTION
2.1 Heart: Overview
2.2 Functions of Heart
2.3 Structural Heart Problem: Overview
2.4 Types of Treatments Structural Heart Problems
2.5 Left Atrial Appendage Closure Device: Overview
2.6 Left Atrial Appendage Closure Device Segmentation: Overview
3. THE US MARKET ANALYSIS
3.1 The US Left Atrial Appendage Closure Device Market: An Analysis
3.1.1 The US Left Atrial Appendage Closure Device Market by Value
3.1.2 The US Left Atrial Appendage Closure Device Market by Product (Epicardial Left Atrial Appendage Closure Device and Endocardial Left Atrial Appendage Closure Device)
3.1.3 The US Left Atrial Appendage Closure Device Market by Procedure (Percutaneous and Surgical)
3.1.3 The US Left Atrial Appendage Closure Device Market by End-Users (Hospitals, Ambulatory Surgery Centres and Others)
3.2 The US Left Atrial Appendage Closure Device Market: Product Analysis
3.2.1 The US Epicardial Left Atrial Appendage Closure Device Market by Value
3.2.2 The US Endocardial Left Atrial Appendage Closure Device Market by Value
3.3 The US Left Atrial Appendage Closure Device Market: Procedure Analysis
3.3.1 The US Percutaneous Left Atrial Appendage Closure Device Market by Value
3.3.2 The US Surgical Left Atrial Appendage Closure Device Market by Value
3.4 The US Left Atrial Appendage Closure Device Market: End-User Analysis
3.4.1 The US Hospital Left Atrial Appendage Closure Device Market by Value
3.4.2 The US Ambulatory Surgery Centres Left Atrial Appendage Closure Device Market by Value
3.4.3 The US Other Left Atrial Appendage Closure Device Market by Value
4. IMPACT OF COVID-19
4.1 COVID-19 Impact on Global Left Atrial Appendage Closure Device Market
4.2 Impact of COVID-19 on Health Services Spending
4.3 Leading Causes of Death in the US
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Aging Population
5.1.2 Growing Disposable Income
5.1.3 Increasing Prevalence of Atrial Fibrillation
5.1.4 Increasing Healthcare Spending Worldwide
5.1.5 Growing Urbanization
5.1.6 Rising Adoption of Minimally Invasive Procedure
5.2 Challenges
5.2.1 High Cost of Left Atrial Appendage Closure Procedure & Equipment
5.2.2 Unfavorable Reimbursement Policies in Developing Countries
5.2.3 High Degree of Competition
5.3 Market Trends
5.3.2 Partnerships among Major Players
5.3.2 Growing Healthcare Market in Emerging Economies
6. COMPETITIVE LANDSCAPE
6.1 The US Left Atrial Appendage Closure Device Market Players: Financial Comparison
6.2 The US Left Atrial Appendage Closure Device Market Players: R&D Comparison
7. COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Abbott
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Boston Scientific
7.3.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.4 AtriCure
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Functions of Heart
Figure 2: Types of Treatments Structural Heart Problems
Figure 3: Segmentation of Left Atrial Appendage Closure Device by Product and End-Users
Figure 4: The US Left Atrial Appendage Closure Device Market by Value; 2016-2020 (US$ Billion)
Figure 5: The US Left Atrial Appendage Closure Device Market by Value; 2021-2025 (US$ Billion)
Figure 6: The US Left Atrial Appendage Closure Device Market by Product; 2020 (Percentage, %)
Figure 7: The US Left Atrial Appendage Closure Device Market by Procedure; 2020 (Percentage, %)
Figure 8: The US Left Atrial Appendage Closure Device Market by End-Users; 2020 (Percentage, %)
Figure 9: The US Epicardial Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 10: The US Endocardial Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 11: The US Percutaneous Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 12: The US Surgical Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 13: The US Hospital Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 14: The US Ambulatory Surgery Centres Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 15: The US Others Left Atrial Appendage Closure Device Market by Value; 2020-2025 (US$ Million)
Figure 16: The US Year-on Year Growth Rate of Health Services Spending by Quarter; (Percentage, %)
Figure 17: Average Daily Deaths in the US; February 2021 (per Day)
Figure 18: The US Population; 2000-2040 (Percentage, %)
Figure 19: The US Total Personal Disposable Income (DPI); 2018-2023 (US$ Billion)
Figure 20: The US Atrial Fibrillation in Adults; 2015-2035 (Million)
Figure 21: Global Healthcare Spending; 2017-2022 (US$ Billion)
Figure 22: The US Urban Population; 2016-2020 (Million)
Figure 23: The US Minimally Invasive Surgery Market Size; (US$ Million)
Figure 24: Johnson & Johnson Net Sales; 2016-2020 (US$ Billon
Figure 25: Johnson & Johnson Net Sales by Segments; 2020 (Percentage, %)
Figure 26: Johnson & Johnson Net Sales by Regions; 2020 (Percentage, %)
Figure 27: Abbott Net Sales; 2016-2020 (US$ Billon)
Figure 28: Abbott Net Sales by Segments; 2020 (Percentage, %)
Figure 29: Abbott Net Sales by Regions; 2020 (Percentage, %)
Figure 30: Boston Scientific Net Sales; 2016-2020 (US$ Billon)
Figure 31: Boston Scientific Net Sales by Segments; 2020 (Percentage, %)
Figure 32: Boston Scientific Net Sales by Regions; 2020 (Percentage, %)
Figure 33: Atricure Revenue; 2016-2020 (US$ Million)
Figure 34: Atricure Revenue by Segments; 2020 (Percentage, %)
Figure 35: Atricure Revenue by Regions; 2020 (Percentage, %)
Table 1: The US Left Atrial Appendage Closure Device Market Players: Financial Comparison; 2020
Table 2: The US Left Atrial Appendage Closure Device Market Players: R&D Comparison; 2016-2020
